Wang Joshua W相关文献与解析，生知库 | 链接生命科学的每一步

Optimization of heterologous DNA-prime, protein boost regimens and site of vaccination to enhance therapeutic immunity against human papillomavirus-associated disease

优化异源DNA启动、蛋白质加强免疫方案和疫苗接种部位，以增强针对人乳头瘤病毒相关疾病的治疗性免疫

Peng, Shiwen; Qiu, Jin; Yang, Andrew; Yang, Benjamin; Jeang, Jessica; Wang, Joshua W; Chang, Yung-Nien; Brayton, Cory; Roden, Richard B S; Hung, Chien-Fu; Wu, T-C

微生物学

免疫/内分泌

发表日期：2016

文献求助收藏

Immunologic Control of Mus musculus Papillomavirus Type 1

小鼠乳头瘤病毒1型的免疫控制

期刊:PLoS Pathogens

影响因子:4.9

doi:10.1371/journal.ppat.1005243

Wang, Joshua W; Jiang, Rosie; Peng, Shiwen; Chang, Yung-Nien; Hung, Chien-Fu; Roden, Richard B S

Durable immunity to oncogenic human papillomaviruses elicited by adjuvanted recombinant Adeno-associated virus-like particle immunogen displaying L2 17-36 epitopes.

佐剂重组腺相关病毒样颗粒免疫原可诱导对致癌性人乳头瘤病毒的持久免疫力，该免疫原显示 L2 17-36 表位

期刊:Vaccine

影响因子:3.5

doi:10.1016/j.vaccine.2015.09.005

Jagu Subhashini, Karanam Balusubramanyam, Wang Joshua W, Zayed Hatem, Weghofer Margit, Brendle Sarah A, Balogh Karla K, Tossi Kerstin Pino, Roden Richard B S, Christensen Neil D

Sequential cisplatin therapy and vaccination with HPV16 E6E7L2 fusion protein in saponin adjuvant GPI-0100 for the treatment of a model HPV16+ cancer

采用顺铂序贯疗法和HPV16 E6E7L2融合蛋白皂苷佐剂GPI-0100疫苗治疗HPV16阳性癌症模型

期刊:PLoS One

影响因子:2.6

doi:10.1371/journal.pone.0116389

Peng, Shiwen; Wang, Joshua W; Karanam, Balasubramanyam; Wang, Chenguang; Huh, Warner K; Alvarez, Ronald D; Pai, Sara I; Hung, Chien-fu; Wu, T-C; Roden, Richard B S

Immunoprevention of human papillomavirus-associated malignancies

人乳头瘤病毒相关恶性肿瘤的免疫预防

期刊:Cancer Prevention Research

影响因子:2.6

doi:10.1158/1940-6207.CAPR-14-0311

Wang, Joshua W; Hung, Chein-Fu; Huh, Warner K; Trimble, Cornelia L; Roden, Richard B S

Seroepidemiology of Human Papillomavirus 16 (HPV16) L2 and Generation of L2-Specific Human Chimeric Monoclonal Antibodies

人乳头瘤病毒16型（HPV16）L2的血清流行病学及L2特异性人嵌合单克隆抗体的制备

期刊:Clinical and Vaccine Immunology

影响因子:

doi:10.1128/CVI.00799-14

Wang, Joshua W; Jagu, Subhashini; Wu, Wai-Hong; Viscidi, Raphael P; Macgregor-Das, Anne; Fogel, Jessica M; Kwak, Kihyuck; Daayana, Sai; Kitchener, Henry; Stern, Peter L; Gravitt, Patti E; Trimble, Cornelia L; Roden, Richard B S

Control of HPV-associated tumors by innovative therapeutic HPV DNA vaccine in the absence of CD4+ T cells

在缺乏CD4+ T细胞的情况下，通过创新型治疗性HPV DNA疫苗控制HPV相关肿瘤

期刊:Cell and Bioscience

影响因子:6.2

doi:10.1186/2045-3701-4-11

Peng, Shiwen; Song, Liwen; Knoff, Jayne; Wang, Joshua W; Chang, Yung-Nien; Hannaman, Drew; Wu, T-C; Alvarez, Ronald D; Roden, Richard Bs; Hung, Chien-Fu

Impact of inhibitors and L2 antibodies upon the infectivity of diverse alpha and beta human papillomavirus types.

抑制剂和 L2 抗体对多种 α 和 β 型人乳头瘤病毒感染性的影响

期刊:PLoS One

影响因子:2.6

doi:10.1371/journal.pone.0097232

Kwak Kihyuck, Jiang Rosie, Wang Joshua W, Jagu Subhashini, Kirnbauer Reinhard, Roden Richard B S

Virus-like particles for the prevention of human papillomavirus-associated malignancies

用于预防人乳头瘤病毒相关恶性肿瘤的病毒样颗粒

期刊:Expert Review of Vaccines

影响因子:4.8

doi:10.1586/erv.12.151

Wang, Joshua W; Roden, Richard B S

Roles of Fc Domain and Exudation in L2 Antibody-Mediated Protection against Human Papillomavirus

Fc结构域和渗出在L2抗体介导的抗人乳头瘤病毒保护中的作用

Optimization of heterologous DNA-prime, protein boost regimens and site of vaccination to enhance therapeutic immunity against human papillomavirus-associated disease

优化异源DNA启动、蛋白质加强免疫方案和疫苗接种部位，以增强针对人乳头瘤病毒相关疾病的治疗性免疫

Immunologic Control of Mus musculus Papillomavirus Type 1

小鼠乳头瘤病毒1型的免疫控制

Durable immunity to oncogenic human papillomaviruses elicited by adjuvanted recombinant Adeno-associated virus-like particle immunogen displaying L2 17-36 epitopes.

佐剂重组腺相关病毒样颗粒免疫原可诱导对致癌性人乳头瘤病毒的持久免疫力，该免疫原显示 L2 17-36 表位

Sequential cisplatin therapy and vaccination with HPV16 E6E7L2 fusion protein in saponin adjuvant GPI-0100 for the treatment of a model HPV16+ cancer

采用顺铂序贯疗法和HPV16 E6E7L2融合蛋白皂苷佐剂GPI-0100疫苗治疗HPV16阳性癌症模型

Immunoprevention of human papillomavirus-associated malignancies

人乳头瘤病毒相关恶性肿瘤的免疫预防

Seroepidemiology of Human Papillomavirus 16 (HPV16) L2 and Generation of L2-Specific Human Chimeric Monoclonal Antibodies

人乳头瘤病毒16型（HPV16）L2的血清流行病学及L2特异性人嵌合单克隆抗体的制备

Control of HPV-associated tumors by innovative therapeutic HPV DNA vaccine in the absence of CD4+ T cells

在缺乏CD4+ T细胞的情况下，通过创新型治疗性HPV DNA疫苗控制HPV相关肿瘤

Impact of inhibitors and L2 antibodies upon the infectivity of diverse alpha and beta human papillomavirus types.

抑制剂和 L2 抗体对多种 α 和 β 型人乳头瘤病毒感染性的影响

Virus-like particles for the prevention of human papillomavirus-associated malignancies

用于预防人乳头瘤病毒相关恶性肿瘤的病毒样颗粒